Evidence map›Paper›PMID 29665000›Full record

ArticleClinical and experimental immunology2018

Increased killer B cells in chronic HCV infection may lead to autoimmunity and increased viral load.

N Eiza, E Zuckerman, M Carlebach, T Rainis, Y Goldberg, Z Vadasz

Open access · bronzeAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

N EizaDivision of Allergy and Clinical Immunology, Bnai Zion Medical Center, Haifa, Israel.
E ZuckermanUnit of Hepatology, Carmel Medical Center, Haifa, Israel.
M CarlebachDivision of Gastroenterology, Bnai Zion Medical Center, Haifa, Israel.
T RainisDivision of Gastroenterology, Bnai Zion Medical Center, Haifa, Israel.
Y GoldbergDepartment of Statistics, University of Haifa, Haifa, Israel.
Z VadaszDivision of Allergy and Clinical Immunology, Bnai Zion Medical Center, Haifa, Israel.ORCID 0000-0003-2899-5508
Bnai Zion Medical Center · ILTechnion – Israel Institute of Technology · ILCarmel Medical Center · ILUniversity of Haifa · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regulatory B (B

Indexed as

AdultAgedAged, 80 and overAntibodies, AntinuclearAntibodies, BlockingApoptosisAutoimmunityB-Lymphocytes, RegulatoryCD4-Positive T-LymphocytesCD5 AntigensCells, CulturedCytotoxicity, ImmunologicFas Ligand ProteinFemaleHepacivirusHepatitis C, ChronicAntibodies, AntinuclearAntibodies, BlockingCD5 AntigensFas Ligand ProteinautoimmunityB cellviral load

Identifiers

PMID29665000
PMCPMC6046472
OpenAlexW2802362212

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.